{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:43:30Z","timestamp":1786729410450,"version":"build-2736575974"},"reference-count":27,"publisher":"BMJ","funder":[{"name":"Australian National Health and Medical Research Council (NHMRC) Investigator Grant","award":["2008379"],"award-info":[{"award-number":["2008379"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ EBM"],"accepted":{"date-parts":[[2026,7,19]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the efficacy of ginger (either stand-alone or as an adjunct treatment) for the treatment and management of migraine headaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, CINAHL, PsycINFO, Epistemonikos and Cochrane CENTRAL from inception to 26 March 2025 which was updated on 16 April 2026 and conducted a backwards and forwards citation search of included studies. We included randomised controlled trials (RCTs) that compared the effect of ginger (either stand-alone or as an adjunct) to placebo or usual active control (such as Depakine (valproic acid), amitriptyline or sumatriptan). Two authors independently screened articles, extracted data, assessed risk of bias using the Cochrane Risk of Bias 2 Tool (ROB-2) tool. Primary outcomes included headache severity or pain scores post-treatment, proportion of patients pain free or with pain relief post-treatment, frequency and duration of migraine attacks and migraine-associated symptoms. Random-effects meta-analyses were done and the certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight RCTs involving 594 patients were included. For acute treatments, ginger with ketoprofen compared with placebo with ketoprofen may have little to no difference on headache severity at 2\u2009hours post (mean difference (MD) 1.27 lower, 95%\u2009CI 1.46 lower to 1.08 lower; 1 study, 60 participants; low certainty evidence). It was very uncertain if ginger combined with feverfew versus placebo or ginger alone compared with sumatriptan improved proportions of those with pain relief, pain free or the mean headache severity at 2\u2009hours post. For preventative treatment, ginger in addition to an active drug compared with the same active drug with or without placebo, may result in an important reduction in headache pain severity at 3 months (pooled MD \u22123.18, 95%\u2009CI \u22123.94 to \u22122.42; 2 studies, 183 participants; low certainty evidence). However, it was very uncertain if ginger combined with herbs compared with active drugs of both Depakine and amitriptyline lowered headache frequency, duration or headache severity at 3 months. The overall certainty of evidence for all outcome measures ranged from low to very low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The volume of the existing evidence is limited and combined with either a low or very low certainty of evidence, it is currently too uncertain if ginger is effective either as an acute or preventative treatment. Therefore, additional acute and preventative trials are required to help raise the certainty of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251025768\">https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251025768<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjebm-2025-114382","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:20:26Z","timestamp":1786728026000},"page":"bmjebm-2025-114382","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Ginger for the treatment and prevention of migraine headaches: a systematic review and meta-analysis of randomised controlled trials"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4564-6859","authenticated-orcid":false,"given":"Tiffany","family":"Atkins","sequence":"first","affiliation":[{"name":"Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-3811","authenticated-orcid":false,"given":"Sam","family":"Manger","sequence":"additional","affiliation":[{"name":"College of Medicine and Dentistry, James Cook University, Townsville City, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-9106","authenticated-orcid":false,"given":"Loai","family":"Albarqouni","sequence":"additional","affiliation":[{"name":"Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia"},{"name":"Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"2026081410201835000_bmjebm-2025-114382v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(24)00038-3"},{"key":"2026081410201835000_bmjebm-2025-114382v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30478-1"},{"key":"2026081410201835000_bmjebm-2025-114382v1.3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.18773\/austprescr.2020.047","article-title":"Migraine management","volume":"43","author":"Jenkins","year":"2020","journal-title":"Aust Prescr"},{"key":"2026081410201835000_bmjebm-2025-114382v1.4","doi-asserted-by":"crossref","first-page":"3331024241267309","DOI":"10.1177\/03331024241267309","article-title":"Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action","volume":"44","author":"Peres","year":"2024","journal-title":"Cephalalgia"},{"key":"2026081410201835000_bmjebm-2025-114382v1.5","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241252666"},{"key":"2026081410201835000_bmjebm-2025-114382v1.6","first-page":"S30","article-title":"Prophylactic Treatment of Migraine","volume":"50","author":"G\u00fcrsoy","year":"2013","journal-title":"Noro Psikiyatr Ars"},{"key":"2026081410201835000_bmjebm-2025-114382v1.7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1874467215666220211100256","article-title":"Preventive and Therapeutic Aspects of Migraine for Patient Care: An Insight","volume":"16","author":"Tiwari","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"2026081410201835000_bmjebm-2025-114382v1.8","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-015-0498-8","article-title":"Improving medication adherence in migraine treatment","volume":"19","author":"Seng","year":"2015","journal-title":"Curr Pain Headache Rep"},{"key":"2026081410201835000_bmjebm-2025-114382v1.9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/NT.0b013e3181ed3543","article-title":"Ginger:An overview of Health Benefits","volume":"45","author":"Singletary","year":"2010","journal-title":"Nutr Today"},{"key":"2026081410201835000_bmjebm-2025-114382v1.10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.phytochem.2015.07.012","article-title":"Gingerols and shogaols: Important nutraceutical principles from ginger","volume":"117","author":"Semwal","year":"2015","journal-title":"Phytochemistry"},{"key":"2026081410201835000_bmjebm-2025-114382v1.11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajem.2020.11.030","article-title":"The efficacy of ginger for the treatment of migraine: A meta-analysis of randomized controlled studies","volume":"46","author":"Chen","year":"2021","journal-title":"Am J Emerg Med"},{"key":"2026081410201835000_bmjebm-2025-114382v1.12","unstructured":"Higgins J , Chandler J , Cumpston M , et al . Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024. Available: www.cochrane.org\/handbook"},{"key":"2026081410201835000_bmjebm-2025-114382v1.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026081410201835000_bmjebm-2025-114382v1.14","unstructured":"Institute For Evidence-Based Healthcare BU . TERA the evidence review accelerator. Bond University; 2025. Available: https:\/\/tera-tools.com"},{"key":"2026081410201835000_bmjebm-2025-114382v1.15","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Chandler J , Cumpston M . Cochrane Handbook for Systematic Reviews of Interventions. 2nd edn. The Cochrane Collaboration, 2019. Available: https:\/\/onlinelibrary.wiley.com\/doi\/book\/10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"2026081410201835000_bmjebm-2025-114382v1.16","unstructured":"StataCorp . Stata statistical software: release 16.1. College Station, TX StataCorp LLC; 2020."},{"key":"2026081410201835000_bmjebm-2025-114382v1.17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026081410201835000_bmjebm-2025-114382v1.18","unstructured":"Atkins T , Manger S , Albarqouni L . Data from: ginger for the treatment and prevention of migraine headaches: a systematic review and meta-analysis of randomised controlled trials. Open Science Framework; 2026. Available: https:\/\/doi.org\/10.17605\/OSF.IO\/XN9FM"},{"key":"2026081410201835000_bmjebm-2025-114382v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"key":"2026081410201835000_bmjebm-2025-114382v1.20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9872933","article-title":"Evaluation of a Polyherbal Formulation on the Management of Migraine Headaches due to Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial","volume":"2022","author":"Anushiravani","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"2026081410201835000_bmjebm-2025-114382v1.21","unstructured":"Aurora S , Vermaas AR , Barrodale PM . Gelstat is effective in relieving migraine pain in a double-blind, placebo-controlled study. American Academy of Neruaology 58th Annual Meeting April 6; 2006"},{"key":"2026081410201835000_bmjebm-2025-114382v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01910.x"},{"key":"2026081410201835000_bmjebm-2025-114382v1.23","doi-asserted-by":"crossref","unstructured":"Helli B , Anjirizadeh F , Mehramiri A , et al . The Effect of Ginger (Zingiber officinale Rosc.) Consumption in Headache Prophylaxis in Patients with Migraine: A Randomized Placebo-Controlled Clinical Trial. Jundishapur J Nat Pharm Prod 2022;17. doi:10.5812\/jjnpp-120449","DOI":"10.5812\/jjnpp-120449"},{"key":"2026081410201835000_bmjebm-2025-114382v1.24","unstructured":"Jivad NSZ , Mardani M . Ginger (zingiber officinale roscoe) and depakene on pain reduction in patients with migraine headaches compared to depakene alone. 2023."},{"key":"2026081410201835000_bmjebm-2025-114382v1.25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ptr.4996","article-title":"Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine","volume":"28","author":"Maghbooli","year":"2014","journal-title":"Phytother Res"},{"key":"2026081410201835000_bmjebm-2025-114382v1.26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0333102419869319","article-title":"Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) in the prophylactic treatment of migraine","volume":"40","author":"Martins","year":"2020","journal-title":"Cephalalgia"},{"key":"2026081410201835000_bmjebm-2025-114382v1.27","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418776016"}],"container-title":["BMJ Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjebm-2025-114382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:20:29Z","timestamp":1786728029000},"score":1,"resource":{"primary":{"URL":"https:\/\/ebm.bmj.com\/lookup\/doi\/10.1136\/bmjebm-2025-114382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":27,"alternative-id":["10.1136\/bmjebm-2025-114382"],"URL":"https:\/\/doi.org\/10.1136\/bmjebm-2025-114382","relation":{},"ISSN":["2515-446X","2515-4478"],"issn-type":[{"value":"2515-446X","type":"print"},{"value":"2515-4478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}